Tebas P - Search Results

1

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, Anderson R, Clendeninn N; Virqacept Collaborative Study Group. Saag MS, et al. Among authors: tebas p. AIDS. 2001 Oct 19;15(15):1971-8. doi: 10.1097/00002030-200110190-00009. AIDS. 2001. PMID: 11600825 Clinical Trial.

2

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly WG, Henry K. Tebas P, et al. AIDS. 1999 Feb 4;13(2):F23-8. doi: 10.1097/00002030-199902040-00002. AIDS. 1999. PMID: 10202820 Clinical Trial.

3

Nelfinavir, a new protease inhibitor: early clinical results.

Powderly WG, Tebas P. Powderly WG, et al. Among authors: tebas p. AIDS. 1999 Sep;13 Suppl 1:S41-8. AIDS. 1999. PMID: 10546784 Review.

4

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Tebas P, et al. AIDS. 2000 Mar 10;14(4):F63-7. doi: 10.1097/00002030-200003100-00005. AIDS. 2000. PMID: 10770534 Free PMC article.

5

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.

Ioannidis JP, Havlir DV, Tebas P, Hirsch MS, Collier AC, Richman DD. Ioannidis JP, et al. Among authors: tebas p. AIDS. 2000 Jul 28;14(11):1481-8. doi: 10.1097/00002030-200007280-00003. AIDS. 2000. PMID: 10983634

6

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M. Squires KE, et al. Among authors: tebas p. AIDS. 2000 Jul 28;14(11):1591-600. doi: 10.1097/00002030-200007280-00015. AIDS. 2000. PMID: 10983646 Clinical Trial.

7

Response to 'Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy' by Drs Weil and Lenhard.

Tebas P, Powderly W, Yarasheski K. Tebas P, et al. AIDS. 2000 Oct 20;14(15):2417. doi: 10.1097/00002030-200010200-00031. AIDS. 2000. PMID: 11089638 No abstract available.

8

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.

Zhou XJ, Havlir DV, Richman DD, Acosta EP, Hirsch M, Collier AC, Tebas P, Sommadossi JP; AIDS Clinical Trials Study 343 Investigators. Zhou XJ, et al. Among authors: tebas p. AIDS. 2000 Dec 22;14(18):2869-76. doi: 10.1097/00002030-200012220-00008. AIDS. 2000. PMID: 11153668 Clinical Trial.

9

Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy.

Tebas P, Henry K, Nease R, Murphy R, Phair J, Powderly WG. Tebas P, et al. AIDS. 2001 Mar 30;15(5):591-9. doi: 10.1097/00002030-200103300-00008. AIDS. 2001. PMID: 11316996

10

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.

Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD; ACTG 5025 Study Group. Havlir DV, et al. Among authors: tebas p. AIDS. 2001 Jul 27;15(11):1379-88. doi: 10.1097/00002030-200107270-00007. AIDS. 2001. PMID: 11504959 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page